Skip to main content
AAPS PharmSci logoLink to AAPS PharmSci
. 2000 Mar 23;2(1):80–87. doi: 10.1208/ps020109

Comparative evaluation of the degree of indomethacin crystallinity by chemoinfometrical fourie-transformed near-infrared spectroscopy and conventional powder X-ray diffractiometry

Makoto Otsuka 1,, Fumie Kato 1, Yoshihisa Matsuda 1
PMCID: PMC2751004  PMID: 11741225

Abstract

A chemoinfometrical method for evaluating the degree of crystallinity based on fourie-transformed near-infrared (FT-NIR) spectroscopy was established and compared with the conventional powder X-ray diffraction method. Powder X-ray diffraction profiles and FT-NIR spectra were recorded for 11 kinds of standard materials with various degrees of crystallinity obtained by physically mixing crystalline and amorphous indomethacin (IMC). Chemoinfometric analysis was performed on the FT-NIR spectral data sets by multiple linear regression (MLR) (MLR-Set-Up Search program). The crystalline and amorphous forms showed significant NIR spectral peaks. MLR analysis was performed based on normalized NIR spectra sets for standard samples of known crystallinity. A calibration equation was determined to minimize the root mean square error of prediction. The predicted crystallinity values were reproducible and had a smaller standard deviation. The values of crystallinity predicted by X-ray powder diffractometry and FT-NIR spectrometry suggested a satisfactory correlation between the 2 techniques. The results indicated that FT-NIR spectroscopy provides for an accurate quantitative analysis of crystallinity compared with conventional X-ray diffractometry.

References

  • 1.FDA Paper. Guidelines: Manufacturing and controls for INDs and NDAs. Pharm Tech Japan. 1985; 1: 835.
  • 2.Otsuka M, Matsuda Y. Polymorphism pharmaceutical aspects. In: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker; 1995. pp. 305–326. [Google Scholar]
  • 3.Black D B, Lovering EG. Estimation of the degree of crystallinity in digoxin by X-ray and infrared methods. J Pharm Pharmacol. 197;29:684–687. doi: 10.1111/j.2042-7158.1977.tb11435.x. [DOI] [PubMed] [Google Scholar]
  • 4.Fuchs S, Schmidt T, Jerosch J. Change in crystallinity by sterilization and processing of ultrahigh molecular polyethylene used in endoprosthetics. Unfallchirung. 1998;101:382–387. doi: 10.1007/s001130050284. [DOI] [PubMed] [Google Scholar]
  • 5.Yoshino H, Hagiwara Y, Kobayashi S, Samejima M. Estimation of polymorphic transformation degree of pharmaceutical raw materials. Chem Pharm Bull. 1984;32:1523–1536. [Google Scholar]
  • 6.Otsuka M, Kaneniwa N. A kinetic study of the crystallization process of noncrystalline indomethacin under isothermal conditions. Chem Pharm Bull. 1988;36:4026–4032. doi: 10.1248/cpb.36.4026. [DOI] [PubMed] [Google Scholar]
  • 7.Taylor LS, Zograf G. The quantitative analysis of crystallinity using FT-raman spectroscopy. Pharm Res. 1998;15:755–761. doi: 10.1023/A:1011979221685. [DOI] [PubMed] [Google Scholar]
  • 8.Ahmed H, Buckton G, Rawlins DA. The use of isothermal microcalorimetry in the study of small degree of amorphous content of a hydrophobic powder. Int J Pharm. 1996;130:195–201. doi: 10.1016/0378-5173(95)04288-1. [DOI] [Google Scholar]
  • 9.Berntsson O, Zackrisson G, Östling G. Determination of moisture in hard gelatin capsules using near-infrared spectroscopy applications to at-time process control of pharmaceutics. J Pharm Biomed Anal. 1997;15:895–890. doi: 10.1016/S0731-7085(96)01926-7. [DOI] [PubMed] [Google Scholar]
  • 10.Buckton G, Yonemochi E, Hammond J, Mofat A. The use of near infra-red spectroscopy to detect changes in the form of amorphous and crystalline lactose. Int J Pharm. 1998;168:231–241. doi: 10.1016/S0378-5173(98)00095-7. [DOI] [Google Scholar]
  • 11.Buchanan BR, Baxter MA, Chen TS, Qin XZ, Robinson PA. Use of near-infrared spectroscopy to evaluated an active in a film coated tablet. Pharm Res. 1996;13:616–621. doi: 10.1023/A:1016014625418. [DOI] [PubMed] [Google Scholar]
  • 12.Bianco M, Coello J, Iturriaga H, Maspoch S, Serrano D. Near-infrared analytical control of pharmaceuticals. A single calibration model from mixed phase to coated tablets. Analyst. 1998;123:2307–2312. doi: 10.1039/a805946b. [DOI] [PubMed] [Google Scholar]
  • 13.Franke P, Gill I, Luscombe CN, Rudd DR, Waterhouse J, Jayasooriya UA. Near-infrared mass medican particle size determination of lactose monohydrate, evaluating several chemometric approaches. Analyst. 1998;123:2043–2046. doi: 10.1039/a802532k. [DOI] [PubMed] [Google Scholar]
  • 14.Morisseau KM, Rhodes CT. Near-infrared spectroscopy as a nondestructive alternative to conventional tablet hardness testing. Pharm Res. 1997;14:108–111. doi: 10.1023/A:1012071904673. [DOI] [PubMed] [Google Scholar]
  • 15.Martens H, Naes T. Multivariate Calibration. New York: John Wiley & Sons; 1989. [Google Scholar]
  • 16.Kaneniwa N, Otsuka M, Hayashi T. Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol. Chem Pharm Bull. 1985;33:3447–3455. doi: 10.1248/cpb.33.3447. [DOI] [PubMed] [Google Scholar]
  • 17.Andronis V, Yoshioka M, Zografi G. Effect of sorbed water on the crystallinzation of indomethacin from the amorphous state. J Pharm Sci. 1997;86:346–351. doi: 10.1021/js9602711. [DOI] [PubMed] [Google Scholar]
  • 18.Andronis V, Zografi G. Molecular mobility of supercooled amorphous indomethacin, determined by dynamic mechanical analysis. Pharm Res. 1997;14:410–414. doi: 10.1023/A:1012026911459. [DOI] [PubMed] [Google Scholar]
  • 19.Iwamoto M, Kwano S, Uozumi J. Introduction of Near-Infrared Sepctrometry. Tokyo: Saiwai Shobon Press; 1994. pp. 51–51. [Google Scholar]
  • 20.Loll PJ, Garavito RM, Carrell CJ, Carrell HL. 1-(4-Iodobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid, and indinated indomethacin analog. Acta Cryst. 1996;52:455–457. doi: 10.1107/S0108270195010468. [DOI] [PubMed] [Google Scholar]
  • 21.Izutsu K, Yoshioka S, Kojima S, Randolph TW, Carpenter JF. Effect of sugars and polymers on crystallization of poly(ethylene glycol) in frozen solutions: phase separation between incompatible polymers. Pharm Res. 1996;13:1393–1400. doi: 10.1023/A:1016086319851. [DOI] [PubMed] [Google Scholar]

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES